Health and Healthcare

Biogen : BIIB

All Biogen Articles

607 Articles

Chris Lange | Jan 25, 2017 at 11:25 AM EST

What to Expect From Major Health Care Stocks Reporting This Week

The health care sector has some of its biggest players reporting later this week, with one pharma giant’s report already…

Chris Lange | Jan 17, 2017 at 11:05 AM EST

Tuesday’s Top Biopharma Movers

A few biotech and pharma companies were on the move Tuesday. A few of the smaller caps made tremendous gains…

Chris Lange | Jan 12, 2017 at 9:35 AM EST

Biotech Short Sellers Run for Cover

As we have approached Trump’s inauguration, the health care sector in general has rallied. Now it’s time to see what…

Lee Jackson | Dec 29, 2016 at 9:25 AM EST

Top Analyst Upgrades and Downgrades: Biogen, Comerica, Deere, NVIDIA, 21st Century Fox and More

Thursday’s top analyst upgrades, downgrades and initiations include Biogen, Comerica, Deere, NVIDIA and Twenty-First Century Fox.

Chris Lange | Dec 28, 2016 at 10:10 AM EST

Biotech Short Interest Sinks

The December 15 short interest data have been compared with the previous report, and short interest was down in most…

Lee Jackson | Dec 27, 2016 at 10:05 AM EST

Top Analysts Upgrades and Downgrades: Biogen, FedEx, Lions Gate, Rexnord, Ionis Pharmaceutical and More

Tuesday’s top analyst upgrades, downgrades and initiations include Biogen, FedEx, Lionsgate Entertainment, Rexnord and RoadRunner Transportation.

Lee Jackson | Dec 22, 2016 at 8:25 AM EST

RBC Likes Large Cap Biotech Leaders for 2017

In a new research report, the biotech team at RBC reveal their top picks for 2017, and while hardly pounding…

Lee Jackson | Dec 16, 2016 at 8:55 AM EST

Top Analysts Upgrades and Downgrades: Apple, Biogen, FedEx, GE, Las Vegas Sands and More

Friday's top analyst upgrades, downgrades and initiations include Apple, Biogen, FedEx, General Electric and Las Vegas Sands.

Chris Lange | Dec 12, 2016 at 9:10 AM EST

Biotech Short Interest Remains Mixed

The November 30 short interest data have been compared with the previous report, and short interest was mixed in the…

Lee Jackson | Dec 9, 2016 at 8:55 AM EST

Top Analyst Upgrades and Downgrades: Alliance Data, Autodesk, Biogen, Broadcom, Delta Air Lines, Finisar and More

Friday’s top analyst upgrades, downgrades and initiations include Alliance Data, Autodesk, Biogen, Broadcom, Delta Air Lines and Finisar.

Chris Lange | Nov 28, 2016 at 7:35 AM EST

Short Sellers Grow More Aggressive on Major Biotechs

The November 15 short interest data have been compared with the previous report, and short interest increased in most of…

Chris Lange | Nov 10, 2016 at 7:20 AM EST

Short Sellers Grow More Selective on Major Biotechs

Now that the U.S. presidential election is over and Hillary Clinton is out of the picture, major biotech companies can…

Chris Lange | Nov 7, 2016 at 9:05 AM EST

Why These 2 Biopharma Companies Are Running

Shares of Ionis Pharmaceuticals and Biogen were on the move Monday morning after the companies announced positive interim results from…

Chris Lange | Oct 26, 2016 at 10:05 AM EDT

Biogen Rises on Solid Earnings Beat

Biogen reported better-than-expected third-quarter financial results before the markets opened on Wednesday,

Chris Lange | Oct 26, 2016 at 7:15 AM EDT

Short Sellers Can’t Make Up Their Minds on Major Biotechs

The October 14 short interest data have been compared with the previous report, and short interest moves in these selected…

1 … 17 18 19 20 21 … 41

Biogen : BIIB

All Biogen Articles

What to Expect From Major Health Care Stocks Reporting This Week

Tuesday’s Top Biopharma Movers

Biotech Short Sellers Run for Cover

Top Analyst Upgrades and Downgrades: Biogen, Comerica, Deere, NVIDIA, 21st Century Fox and More

Biotech Short Interest Sinks

Top Analysts Upgrades and Downgrades: Biogen, FedEx, Lions Gate, Rexnord, Ionis Pharmaceutical and More

RBC Likes Large Cap Biotech Leaders for 2017

Top Analysts Upgrades and Downgrades: Apple, Biogen, FedEx, GE, Las Vegas Sands and More

Biotech Short Interest Remains Mixed

Top Analyst Upgrades and Downgrades: Alliance Data, Autodesk, Biogen, Broadcom, Delta Air Lines, Finisar and More

Short Sellers Grow More Aggressive on Major Biotechs

Short Sellers Grow More Selective on Major Biotechs

Why These 2 Biopharma Companies Are Running

Biogen Rises on Solid Earnings Beat

Short Sellers Can’t Make Up Their Minds on Major Biotechs

QQQI Yields You Almost 14%, but Can It Survive a Dot-Com-Style Recession?

XOP vs. OIH: Do Drillers or Service Providers Best Ride Crude Above $100?

A 52-Year-Old With $1.2 Million in a 401(k) Can Access $40,000 Annually Penalty-Free at 57 Using This Strategy

A 52-Year-Old With $1.2 Million in a 401(k) Can Access $40,000 Annually Penalty-Free at 57 Using This Strategy

America's Debt Just Crossed a Level It Hasn't Hit Since 1946, and Households Are Next in Line

QQQI Yields You Almost 14%, but Can It Survive a Dot-Com-Style Recession?

XOP vs. OIH: Do Drillers or Service Providers Best Ride Crude Above $100?

Biogen : BIIB

All Biogen Articles

What to Expect From Major Health Care Stocks Reporting This Week

Tuesday’s Top Biopharma Movers

Biotech Short Sellers Run for Cover

Top Analyst Upgrades and Downgrades: Biogen, Comerica, Deere, NVIDIA, 21st Century Fox and More

Biotech Short Interest Sinks

Top Analysts Upgrades and Downgrades: Biogen, FedEx, Lions Gate, Rexnord, Ionis Pharmaceutical and More

RBC Likes Large Cap Biotech Leaders for 2017

Top Analysts Upgrades and Downgrades: Apple, Biogen, FedEx, GE, Las Vegas Sands and More

Biotech Short Interest Remains Mixed

Top Analyst Upgrades and Downgrades: Alliance Data, Autodesk, Biogen, Broadcom, Delta Air Lines, Finisar and More

Short Sellers Grow More Aggressive on Major Biotechs

Short Sellers Grow More Selective on Major Biotechs

Why These 2 Biopharma Companies Are Running

Biogen Rises on Solid Earnings Beat

Short Sellers Can’t Make Up Their Minds on Major Biotechs

QQQI Yields You Almost 14%, but Can It Survive a Dot-Com-Style Recession?

XOP vs. OIH: Do Drillers or Service Providers Best Ride Crude Above $100?

A 52-Year-Old With $1.2 Million in a 401(k) Can Access $40,000 Annually Penalty-Free at 57 Using This Strategy

Featured Reads

A 52-Year-Old With $1.2 Million in a 401(k) Can Access $40,000 Annually Penalty-Free at 57 Using This Strategy

America's Debt Just Crossed a Level It Hasn't Hit Since 1946, and Households Are Next in Line